Now, in research at the University of Georgia, a cellular biologist and his colleagues have found that Hirano bodies may play a protective role in the progression of neurodegenerative diseases such as Alzheimer's. And to find out why this may be happening, they have developed the world's first transgenic mouse model that has Hirano bodies, which will open new frontiers on how these poorly understood structures may be involved with some of humankind's most difficult-to-treat diseases.
"This work gives us a first view of the possible effects of Hirano bodies," said Marcus Fechheimer, Josiah Meigs Professor of cellular biology at UGA. "Now we know that Hirano bodies do not kill cells and are not toxic to mice. This new model will allow us to ask whether Hirano bodies have any effect on progression of disease in the brain."
While the research offers no cure for diseases such as Lou Gehrig's and mad cow, it does create a new area of research into understanding how these diseases operate in the human body and why they are so difficult to treat. And the problem is vast: the Alzheimer's Association reports there are 5.4 million sufferers of that disease in the U.S. alone.
The latest research announcing the transgenic mouse model for the formation of Hirano bodies was just published in the journal BMC Neuroscience. Co-authors with Fechheimer include Ruth Furukawa in the Fechheimer lab at UGA, as well as John Wagner and Michael Stramiello of the College of Veterinary Medicine, also at UGA; and Sangdeuk Ha, formerly of UGA and now with Beth Israel Deconess Medical Center at the Harvard Medical School.
Researchers actually discovered Hirano bodies decades ago but studying them in the lab proved so difficult that all the medical community could say was that the bodies were in some way associated with diseases such as Alzheimer's. It was clear that Hirano bodies are composed primarily of filaments of actin, a protein that participates in many important cellular processes. But no one understood their function.
Fechheimer's lab has been at the center of research on Hirano bodies for nearly a decade. In 2002, it reported for the first time a method of inducing the bodies to form. Interestingly, these "inclusions" also show up in autopsies of people suffering from diabetes, alcoholism and cancer. Hirano bodies also are associated with normal aging. So understanding what they do when neurological processes go off the rails could add an important step in understanding how diseases that cause so much suffering progress.
In a companion paper to the new mouse model research, published this year in the journal Neurobiology of Aging, Fechheimer and his co-authors discovered that Hirano bodies may actually act as a "corral" into which more damaging cellular molecules are "rounded up," thus actually promoting cell survival and possibly even slowing the impact of disease. The idea that Hirano bodies may actually help protect cells from such disorders as Alzheimer's came as a surprise to the team, though much research remains to be done to make sure exactly what is happening.
Co-authors on the paper in Neurobiology of Aging were Furukawa and Ha.
"The new results show us that Hirano bodies reduce cell death in a model system in a culture dish," said Fechheimer. "Now we need to know if Hirano bodies have any harmful or protective effects on cells in the brain in a mouse and in human patients. We developed the new mouse model to begin to answer this question."
The new model system will allow Fechheimer and his colleagues to study the impact of Hirano bodies in a living, mammalian system and to investigate the pathways for formation and degradation of the bodies. It will also allow them to test whether Hirano bodies promote or modulate the development of pathology or affect the deterioration of learning and memory that characterize both the human disease and the mouse models of these conditions.
The mouse model research was supported by grants from the Alzheimer's Association and the National Institutes of Health. The NIH and Alzheimer's Association, as well as the National Science Foundation also supported the research reported in Neurobiology of Aging.
Note to editors: An image of Fechheimer in his laboratory is available for download at http://multimedia.uga.edu/media/images/Fechheimer_Marcus.jpg
Marcus Fechheimer | EurekAlert!
The balancing act: An enzyme that links endocytosis to membrane recycling
07.12.2016 | National Centre for Biological Sciences
Transforming plant cells from generalists to specialists
07.12.2016 | Duke University
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
07.12.2016 | Health and Medicine
07.12.2016 | Life Sciences
07.12.2016 | Health and Medicine